Strontium-89 Therapy for Breast Cancer Bone Metastases: Pain Relief Effects and Predictive Factors

MLA

Yasuyuki Kojima, et al. “Strontium-89 Therapy for Breast Cancer Bone Metastases: Pain Relief Effects and Predictive Factors.” Advances in Breast Cancer Research, Jan. 2018, pp. 250–57. EBSCOhost, https://doi.org/10.4236/abcr.2018.74016.

APA

Yasuyuki Kojima, Koichiro Tsugawa, Tomoko Uejima, Mio Shinozaki, Yasuo Nakajima, Tatsuyuki Abe, Hiromichi Gomi, Shinjiro Sakaino, & Yukinori Okada. (2018). Strontium-89 Therapy for Breast Cancer Bone Metastases: Pain Relief Effects and Predictive Factors. Advances in Breast Cancer Research, 250–257. https://doi.org/10.4236/abcr.2018.74016

Chicago

Yasuyuki Kojima, Koichiro Tsugawa, Tomoko Uejima, Mio Shinozaki, Yasuo Nakajima, Tatsuyuki Abe, Hiromichi Gomi, Shinjiro Sakaino, and Yukinori Okada. 2018. “Strontium-89 Therapy for Breast Cancer Bone Metastases: Pain Relief Effects and Predictive Factors.” Advances in Breast Cancer Research, January, 250–57. doi:10.4236/abcr.2018.74016.